Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Adjunctive 308-nm Excimer Light During Oral Azithromycin Therapy for Inflammatory Acne Vulgaris: A Randomized, Evaluator-Blinded, Split-Face Controlled Trial

NCT07777952 is registered in ClinicalTrials.gov with Mahmoud Rageh as lead sponsor.

NCT NCT07777952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07777952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Adjunctive 308-nm Excimer Light During Oral Azithromycin Therapy for Inflammatory Acne Vulgaris: A Randomized, Evaluator-Blinded, Split-Face Controlled Trial
Lead sponsor
Mahmoud Rageh
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2025
Completion date
May 10, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris